Rahul Singhvi
Director/Board Member at CODEXIS, INC.
Net worth: 230 162 $ as of 2024-03-30
Profile
Rahul Singhvi is the founder of National Resilience, Inc. where he currently serves as the Chief Executive Officer & Director.
He is also the founder of Axella Solutions LLC.
Dr. Singhvi's current jobs include being the Chief Executive Officer of Swiftscale Biologics, Inc. and Resilience Biotechnologies, Inc. He is also an Independent Director at Codexis, Inc., a Director at Garuda Therapeutics, Inc., and a Trustee at Keck Graduate Institute of Applied Life Sciences.
Dr. Singhvi's former jobs include being the President & Chief Executive Officer of Novavax, Inc., Director-Manufacturing Division at Merck & Co., Inc., Lead Independent Director at ImmunoCellular Therapeutics Ltd., and Chief Operating Officer at Magnum Hunter Resources, Inc. He has also held positions as a Director at NewGen BioPharma Corp., Univercells SA, and Valor Biotherapeutics LLC.
Dr. Singhvi's education includes a graduate and doctorate degree from Massachusetts Institute of Technology, an undergraduate degree from Indian Institute of Technology Kanpur, and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC.
0.09% | 2023-11-08 | 65,949 ( 0.09% ) | 230 162 $ | 2024-03-30 |
Rahul Singhvi active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Director/Board Member | 2022-09-27 |
Swiftscale Biologics, Inc.
 Swiftscale Biologics, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Swiftscale Biologics, Inc. develops protein synthesis technologies. The private company is based in La Jolla, CA. The company was founded in 2018 by Michael Jewett, Matthew DeLisa. The CEO is Rahul Singhvi. Swiftscale Biologics was acquired by National Resilience, Inc. on December 02, 2021. | Chief Executive Officer | - |
Resilience Biotechnologies, Inc.
 Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the private company is Rahul Singhvi. | Chief Executive Officer | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Director/Board Member | - |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Founder | 2019-12-31 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | President | 2019-11-30 |
| Axella Solutions LLC | Founder | - |
| Keck Graduate Institute of Applied Life Sciences | Director/Board Member | - |
Former positions of Rahul Singhvi
| Companies | Position | End |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 2020-06-30 |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Rahul Singhvi
| Massachusetts Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Kanpur | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| Private companies | 15 |
|---|---|
Magnum Hunter Resources, Inc.
 Magnum Hunter Resources, Inc. Integrated OilEnergy Minerals Magnum Hunter Resources, Inc. provides oil exploration and drilling services. The company is headquartered in Irving, TX | Energy Minerals |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Bill, Hillary & Chelsea Clinton Foundation
 Bill, Hillary & Chelsea Clinton Foundation Services to the Health IndustryHealth Services Bill, Hillary & Chelsea Clinton Foundation engages in the provision of emergency relief services. It focuses on worldwide issues that demand urgent action, solutions and measurable results - global climate change, Human Immune deficiency/ Acquired Immune Deficiency Syndrome in the developing world, childhood obesity and economic opportunity in the United States and economic development in Africa and Latin America. The company was founded by William Jefferson Clinton in September 2005 and is headquartered in New York, NY. | Health Services |
NewGen BioPharma Corp. /Old/
 NewGen BioPharma Corp. /Old/ Pharmaceuticals: MajorHealth Technology NewGen BioPharma Corp. provides biopharmaceutical products. It develops and commercializes pharmaceuticals and cosmaceuticals through reformulating approved API’s (Active Pharmaceutical Ingredients) using multiple proprietary nanotechnology platforms including the Micellar Nano Particle (MNP) platform. The company was founded by Navdeep S. Jaikaria and is headquartered in Titusville, NJ. | Health Technology |
| Axella Solutions LLC | |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Health Technology |
Takeda Vaccines, Inc.
 Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The private company is based in Bozeman, MT. | Commercial Services |
| Valor Biotherapeutics LLC | |
Swiftscale Biologics, Inc.
Swiftscale Biologics, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Swiftscale Biologics, Inc. develops protein synthesis technologies. The private company is based in La Jolla, CA. The company was founded in 2018 by Michael Jewett, Matthew DeLisa. The CEO is Rahul Singhvi. Swiftscale Biologics was acquired by National Resilience, Inc. on December 02, 2021. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
National Resilience, Inc.
National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Commercial Services |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Health Technology |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the private company is Rahul Singhvi. | Health Technology |
Caliber Biotherapeutics LLC
 Caliber Biotherapeutics LLC Pharmaceuticals: MajorHealth Technology Caliber Biotherapeutics LLC. develops and commercializes protein-based therapeutics that improve outcomes for patients with cancer and other diseases. Its products include CBD Oil, CBD Vape Liquid, CBD Edibles, CBD Crystals, and CBD capsules. The company was founded on July 31, 2009 and is headquartered in Dallas, TX. | Health Technology |
- Stock Market
- Insiders
- Rahul Singhvi
